Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter Veterinary (33) Apply Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Paediatric investigation plans Remove Paediatric investigation plans filter Orphan designations Remove Orphan designations filter Summaries of opinion (22) Apply Summaries of opinion filter Withdrawn applications (36) Apply Withdrawn applications filter Referrals (17) Apply Referrals filter Direct healthcare professional communication (39) Apply Direct healthcare professional communication filter

Product number

Patient safety

Yes (10) Apply Yes filter

Authorisation status

Authorised (605) Apply Authorised filter Refused (2) Apply Refused filter Withdrawn (112) Apply Withdrawn filter

ATC code

Marketing authorisation date

From:

To:

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

From:

To:

PIP decision type

P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) (18) Apply P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) filter PM: decision on the application for modification of an agreed PIP (175) Apply PM: decision on the application for modification of an agreed PIP filter RPM: decision refers to a refusal on the application for modification of an agreed PIP (2) Apply RPM: decision refers to a refusal on the application for modification of an agreed PIP filter RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) (1) Apply RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) filter W: decision granting a waiver in all age groups for all conditions or indications (38) Apply W: decision granting a waiver in all age groups for all conditions or indications filter

PIP condition / indication

Pharmaceutical form(s)

Route(s) of administration

Decision date

From:

To:

PIP compliance check

Yes (27) Apply Yes filter

Compliance procedure number

Orphan designation – intended use

Orphan decision number

Orphan designation status

Positive (134) Apply Positive filter Withdrawn (1) Apply Withdrawn filter

Medicine type

Accelerated assessment Remove Accelerated assessment filter Additional monitoring Remove Additional monitoring filter Conditional approval Remove Conditional approval filter Exceptional circumstances Remove Exceptional circumstances filter Generic Remove Generic filter Biosimilar (95) Apply Biosimilar filter Orphan medicine (514) Apply Orphan medicine filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

1088 results

Remove all filtersRemove all filters

Medicine type Additional monitoring Remove Additional monitoring filter Conditional approval Remove Conditional approval filter Exceptional circumstances Remove Exceptional circumstances filter Generic Remove Generic filter Accelerated assessment Remove Accelerated assessment filter

Medicine Orphan designations Remove Orphan designations filter Paediatric investigation plans Remove Paediatric investigation plans filter European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter

Categories Human Remove Human filter

Sort by

List item

Human medicine European public assessment report (EPAR): Fluad Tetra (updated)

A/Victoria/2570/2019 (H1N1)pdm09 like strain (A/Victoria/2570/2019 IVR‐215) A/Darwin/9/2021 (H3N2) like strain (A/Darwin/6/2021 IVR-227) B/Austria/1359417/2021 like strain (B/Austria/1359417/2021 BVR-26) B/Phuket/3073/2013 like strain (B/Phuket/3073/2013 BVR‐1B), Influenza, Human
Date of authorisation: 20/05/2020, , Revision: 6, Authorised, Last updated: 22/05/2023
List item

Human medicine European public assessment report (EPAR): Eladynos (updated)

abaloparatide, Osteoporosis, Postmenopausal; Osteoporosis ,
Revision: 1, Authorised, Last updated: 22/05/2023
List item

Human medicine European public assessment report (EPAR): Ibrance (updated)

Palbociclib, Breast Neoplasms
Date of authorisation: 09/11/2016, , Revision: 15, Authorised, Last updated: 22/05/2023
List item

Human medicine European public assessment report (EPAR): Kanuma (updated)

sebelipase alfa, Lipid Metabolism, Inborn Errors
Date of authorisation: 28/08/2015, , , , Revision: 9, Authorised, Last updated: 17/05/2023
List item

Human medicine European public assessment report (EPAR): Orphacol (updated)

cholic acid, Digestive System Diseases; Metabolism, Inborn Errors
Date of authorisation: 12/09/2013,
Date of refusal: 25/05/2012, , , , Revision: 13, Authorised, Last updated: 17/05/2023
List item

Human medicine European public assessment report (EPAR): Hemlibra (updated)

Emicizumab, Hemophilia A
Date of authorisation: 23/02/2018, , Revision: 15, Authorised, Last updated: 17/05/2023
List item

Human medicine European public assessment report (EPAR): Fingolimod Accord (updated)

fingolimod hydrochloride , Multiple Sclerosis, Relapsing-Remitting
Date of authorisation: 25/06/2020, , Revision: 3, Authorised, Last updated: 17/05/2023
List item

Human medicine European public assessment report (EPAR): Ritonavir Mylan (updated)

ritonavir, HIV Infections
Date of authorisation: 09/11/2017, , Revision: 14, Authorised, Last updated: 17/05/2023
List item

Human medicine European public assessment report (EPAR): Libtayo (updated)

Cemiplimab, Carcinoma, Squamous Cell
Date of authorisation: 28/06/2019, , Revision: 14, Authorised, Last updated: 17/05/2023
List item

Human medicine European public assessment report (EPAR): Atazanavir Mylan (updated)

atazanavir (as sulfate), HIV Infections
Date of authorisation: 22/08/2016, , Revision: 14, Authorised, Last updated: 17/05/2023
List item

Human medicine European public assessment report (EPAR): Cinacalcet Accordpharma (updated)

cinacalcet hydrochloride, Hyperparathyroidism
Date of authorisation: 03/04/2020, , Revision: 3, Authorised, Last updated: 16/05/2023
List item

Human medicine European public assessment report (EPAR): Febuxostat Mylan (updated)

febuxostat, Hyperuricemia; Arthritis, Gouty; Gout
Date of authorisation: 15/06/2017, , Revision: 11, Authorised, Last updated: 16/05/2023
List item

Human medicine European public assessment report (EPAR): Sirturo (updated)

bedaquiline fumarate, Tuberculosis, Multidrug-Resistant
Date of authorisation: 05/03/2014, , , , Revision: 21, Authorised, Last updated: 16/05/2023
List item

Human medicine European public assessment report (EPAR): Xofigo (updated)

radium (223Ra) dichloride, Prostatic Neoplasms
Date of authorisation: 13/11/2013, , Revision: 13, Authorised, Last updated: 16/05/2023
List item

Human medicine European public assessment report (EPAR): Rozlytrek (updated)

Entrectinib, Cancer; Carcinoma, Non-Small-Cell Lung
Date of authorisation: 31/07/2020, , , Revision: 6, Authorised, Last updated: 15/05/2023
List item

Human medicine European public assessment report (EPAR): Imnovid (previously Pomalidomide Celgene) (updated)

Pomalidomide, Multiple Myeloma
Date of authorisation: 05/08/2013, , , Revision: 22, Authorised, Last updated: 15/05/2023
List item

Human medicine European public assessment report (EPAR): Darunavir Krka (updated)

darunavir, HIV Infections
Date of authorisation: 26/01/2018, , Revision: 10, Authorised, Last updated: 15/05/2023
List item

Human medicine European public assessment report (EPAR): Vaxzevria (previously COVID-19 Vaccine AstraZeneca) (updated)

ChAdOx1-SARS-COV-2, COVID-19 virus infection
Date of authorisation: 29/01/2021, , , Revision: 28, Authorised, Last updated: 12/05/2023
List item

Human medicine European public assessment report (EPAR): Retsevmo (updated)

Selpercatinib, Carcinoma, Non-Small-Cell Lung; Thyroid Neoplasms
Date of authorisation: 11/02/2021, , , Revision: 6, Authorised, Last updated: 12/05/2023
List item

Human medicine European public assessment report (EPAR): Evusheld (updated)

tixagevimab, cilgavimab, COVID-19 virus infection
Date of authorisation: 25/03/2022, , Revision: 2, Authorised, Last updated: 12/05/2023
List item

Human medicine European public assessment report (EPAR): Vaxneuvance (updated)

pneumococcal polysaccharide conjugate vaccine (adsorbed), Pneumococcal Infections
Date of authorisation: 13/12/2021, , Revision: 4, Authorised, Last updated: 12/05/2023
List item

Human medicine European public assessment report (EPAR): Bylvay (updated)

Odevixibat, Cholestasis, Intrahepatic
Date of authorisation: 16/07/2021, , , , Revision: 2, Authorised, Last updated: 12/05/2023
List item

Human medicine European public assessment report (EPAR): Tibsovo (updated)

Ivosidenib, Leukemia, Myeloid, Acute; Cholangiocarcinoma
Date of authorisation: 04/05/2023, , , Authorised, Last updated: 12/05/2023
List item

Human medicine European public assessment report (EPAR): Pemazyre (updated)

pemigatinib, Cholangiocarcinoma
Date of authorisation: 26/03/2021, , , , Revision: 5, Authorised, Last updated: 12/05/2023
List item

Human medicine European public assessment report (EPAR): Lenvima (updated)

lenvatinib mesilate, Thyroid Neoplasms
Date of authorisation: 28/05/2015, , , Revision: 18, Authorised, Last updated: 11/05/2023

Load more

1088 results

Human medicine European public assessment report (EPAR): Fluad Tetra (updated)

Human medicine European public assessment report (EPAR): Eladynos (updated)

Human medicine European public assessment report (EPAR): Ibrance (updated)

Human medicine European public assessment report (EPAR): Kanuma (updated)

Human medicine European public assessment report (EPAR): Orphacol (updated)

Human medicine European public assessment report (EPAR): Hemlibra (updated)

Human medicine European public assessment report (EPAR): Fingolimod Accord (updated)

Human medicine European public assessment report (EPAR): Ritonavir Mylan (updated)

Human medicine European public assessment report (EPAR): Libtayo (updated)

Human medicine European public assessment report (EPAR): Atazanavir Mylan (updated)

Human medicine European public assessment report (EPAR): Cinacalcet Accordpharma (updated)

Human medicine European public assessment report (EPAR): Febuxostat Mylan (updated)

Human medicine European public assessment report (EPAR): Sirturo (updated)

Human medicine European public assessment report (EPAR): Xofigo (updated)

Human medicine European public assessment report (EPAR): Rozlytrek (updated)

Human medicine European public assessment report (EPAR): Imnovid (previously Pomalidomide Celgene) (updated)

Human medicine European public assessment report (EPAR): Darunavir Krka (updated)

Human medicine European public assessment report (EPAR): Vaxzevria (previously COVID-19 Vaccine AstraZeneca) (updated)

Human medicine European public assessment report (EPAR): Retsevmo (updated)

Human medicine European public assessment report (EPAR): Evusheld (updated)

Human medicine European public assessment report (EPAR): Vaxneuvance (updated)

Human medicine European public assessment report (EPAR): Bylvay (updated)

Human medicine European public assessment report (EPAR): Tibsovo (updated)

Human medicine European public assessment report (EPAR): Pemazyre (updated)

Human medicine European public assessment report (EPAR): Lenvima (updated)